bluebird bio, Inc. (BLUE) Social Stream
BLUEBIRD BIO INC (BLUE) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering BLUE.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 14 | $45 | $11 | $23.09 | $1.38 | 1573.19% |
| 2021-11-15 | 14 | $45 | $11 | $22.8 | $1.38 | 1552.17% |
| 2021-11-19 | 14 | $45 | $11 | $20.2 | $1.38 | 1363.77% |
| 2021-12-20 | 13 | $45 | $11 | $20.2 | $1.38 | 1363.77% |
| 2022-01-06 | 13 | $45 | $10 | $20.1 | $1.38 | 1356.52% |
| 2022-01-18 | 13 | $45 | $10 | $19.9 | $1.38 | 1342.03% |
| 2022-02-01 | 12 | $45 | $6 | $19.5 | $1.38 | 1313.04% |
| 2022-03-07 | 12 | $45 | $6 | $19.5 | $1.38 | 1313.04% |
| 2022-03-09 | 13 | $45 | $4 | $18.333 | $1.38 | 1228.48% |
| 2022-05-03 | 13 | $45 | $4 | $18.111 | $1.38 | 1212.39% |
| 2022-05-10 | 13 | $35 | $3 | $14.5 | $1.38 | 950.72% |
| 2022-05-17 | 14 | $35 | $3 | $14.25 | $1.38 | 932.61% |
| 2022-06-12 | 13 | $25 | $2 | $10.125 | $1.38 | 633.7% |
| 2022-08-08 | 12 | $23 | $2 | $8.25 | $1.38 | 497.83% |
| 2022-08-13 | 10 | $23 | $2 | $8.25 | $1.38 | 497.83% |
| 2022-08-19 | 10 | $23 | $2 | $8.5 | $1.38 | 515.94% |
| 2022-09-13 | 10 | $23 | $3 | $8.625 | $1.38 | 525% |
| 2022-09-19 | 10 | $23 | $3 | $8.75 | $1.38 | 534.06% |
| 2022-09-20 | 10 | $23 | $3 | $9 | $1.38 | 552.17% |
| 2022-10-12 | 9 | $10 | $3 | $7 | $1.38 | 407.25% |
| 2022-10-24 | 9 | $10 | $3 | $6.714 | $1.38 | 386.52% |
| 2022-11-08 | 10 | $10 | $3 | $6.714 | $1.38 | 386.52% |
| 2023-01-24 | 10 | $10 | $3 | $7 | $1.38 | 407.25% |
| 2023-02-08 | 10 | $10 | $3 | $6.875 | $1.38 | 398.19% |
| 2023-03-07 | 11 | $10 | $3 | $7.222 | $1.38 | 423.33% |
| 2023-03-30 | 11 | $10 | $3 | $6.555 | $1.38 | 375% |
| 2023-04-13 | 12 | $10 | $3 | $6.222 | $1.38 | 350.87% |
| 2023-05-10 | 12 | $10 | $3 | $6.5 | $1.38 | 371.01% |
| 2023-06-06 | 12 | $10 | $3 | $6.8 | $1.38 | 392.75% |
| 2023-07-13 | 12 | $10 | $3 | $6.9 | $1.38 | 400% |
| 2023-08-08 | 12 | $11 | $3 | $7.3 | $1.38 | 428.99% |
| 2023-08-16 | 12 | $11 | $3 | $7.4 | $1.38 | 436.23% |
| 2023-10-12 | 12 | $11 | $3 | $7.521 | $1.38 | 445% |
| 2023-11-07 | 12 | $11 | $3 | $7.321 | $1.38 | 430.51% |
| 2023-11-08 | 13 | $13 | $3 | $7.11 | $1.38 | 415.22% |
| 2023-12-06 | 13 | $13 | $3 | $7.11 | $1.38 | 415.22% |
| 2023-12-08 | 13 | $13 | $4 | $7.473 | $1.38 | 441.52% |
| 2023-12-11 | 12 | $12 | $3 | $6.321 | $1.38 | 358.04% |
| 2023-12-12 | 12 | $12 | $3 | $6.021 | $1.38 | 336.3% |
| 2023-12-15 | 13 | $12 | $3 | $5.928 | $1.38 | 329.57% |
| 2023-12-19 | 13 | $12 | $3 | $5.746 | $1.38 | 316.38% |
| 2023-12-20 | 13 | $11 | $2 | $5.564 | $1.38 | 303.19% |
The Trend in the Analyst Price Target
Over the past 22 months, BLUE's average price target has gone down $13.31.
BLUE reports an average of 108.67% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-05-10 | 12 | 10 | 3 | 6.300 | 5.03 | 25.25% |
| 2023-07-11 | 12 | 10 | 3 | 6.900 | 3.63 | 90.08% |
| 2023-08-08 | 12 | 11 | 3 | 7.400 | 3.89 | 90.23% |
| 2023-10-12 | 11 | 11 | 3 | 7.321 | 2.61 | 180.5% |
| 2023-11-08 | 12 | 13 | 3 | 7.421 | 3.26 | 127.64% |
BLUE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.54 | 4 | 0 | 8 | 1 | 1 | 13 |
The Trend in the Broker Recommendations
BLUE's average broker recommendation rating improved by 0.56 over the prior 15 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BLUE as an investment opportunity.
- In terms of how BLUEBIRD BIO INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -5496.04% of that group.
- In terms of how BLUEBIRD BIO INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 5577.23% of that group.
- BLUE has a greater average analyst price target than 295.91% of stocks in the large market cap category.
- BLUEBIRD BIO INC's number of analysts covering the stock is higher than 4608.29% of Pharmaceutical Products stocks.
Stocks similar to BLUEBIRD BIO INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NVAX, NBIX, and GILD.
View All Top Stocks by Price Target
Is BLUE a Buy, Hold or Sell? See the POWR Ratings now!